PMID: 8597373Dec 29, 1995Paper

Newborn blood used as a source of donor cells in a murine model of transplantation across non-MHC antigens

Annals of the New York Academy of Sciences
V de La Selle, M Bruley-Rosset

Abstract

Cells derived from human cord blood instead of bone marrow were recently used for transplantation. However, several questions concerning the potential of this source of cells to reconstitute the hematopoietic and immunologic system of the recipient and to induce graft-versus-host disease (GVHD) remain unanswered. We used newborn blood (NBB) cells from B10.D2 mice to engraft lethally irradiated (DBA/2 x B10.D2)F1 recipients incompatible for multiple non-H-2 antigens. The median volume of NBB collected from one mouse ranged between 40 and 50 microliters and the number of nucleated cells was approximately 4-5 x 10(5) per sample. We first established that NBB contains around 10-20% of stem cells (SCA-1+) and 30% of CD4+CD8+ Thy-1+ immature T cells. The injection of blood pooled from one to three newborn mice resulted in engraftment of 71%-86% of F1 recipients that survived more than 100 days. Long-term surviving mice exhibited mixed chimerism (approximately 69% of cells of donor origin) 2-4 months after transplantation, and clinical signs of GVHD across minor histocompatibility Ags (mHAgs) were never observed. Additionally, mixed lymphocyte reaction and cytotoxic assay responses of those mice against host antigens were undetectable...Continue Reading

References

Apr 17, 1975·The New England Journal of Medicine·E ThomasC D Buckner
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerP Rubinstein
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D T HarrisE A Boyse
May 1, 1991·Journal of Cataract and Refractive Surgery·J H TalamoC Enger
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A A CardosoS C Clark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.